127 related articles for article (PubMed ID: 33403394)
1. Branched I antigen regulated cell susceptibility against natural killer cytotoxicity through its N-linked glycosylation and overall expression.
Wu YX; Lu HF; Lin YH; Chuang HY; Su SC; Liao YJ; Twu YC
Glycobiology; 2021 Jun; 31(5):624-635. PubMed ID: 33403394
[TBL] [Abstract][Full Text] [Related]
2. Branched I antigens on leukemia cells enhanced sensitivity against natural killer-cell cytotoxicity through affecting the target-effector interaction.
Lee YH; Liao YJ; Huang CH; Chang FL; Fan TH; Twu YC
Transfusion; 2017 Apr; 57(4):1040-1051. PubMed ID: 28337749
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity protein Tag7 (PGRP-S) activates lymphocytes capable of Fasl-Fas-dependent contact killing of virus-infected cells.
Sharapova TN; Ivanova OK; Prasolov VS; Romanova EA; Sashchenko LP; Yashin DV
IUBMB Life; 2017 Dec; 69(12):971-977. PubMed ID: 29083508
[TBL] [Abstract][Full Text] [Related]
4. A Developed NK-92MI Cell Line with Siglec-7
Huang CH; Liao YJ; Fan TH; Chiou TJ; Lin YH; Twu YC
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617289
[TBL] [Abstract][Full Text] [Related]
5. TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression.
Huang CH; Liao YJ; Chiou TJ; Huang HT; Lin YH; Twu YC
Immunobiology; 2019 Sep; 224(5):649-658. PubMed ID: 31421859
[TBL] [Abstract][Full Text] [Related]
6. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
7. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.
Carbone E; Neri P; Mesuraca M; Fulciniti MT; Otsuki T; Pende D; Groh V; Spies T; Pollio G; Cosman D; Catalano L; Tassone P; Rotoli B; Venuta S
Blood; 2005 Jan; 105(1):251-8. PubMed ID: 15328155
[TBL] [Abstract][Full Text] [Related]
8. Fas involvement in human NK cell apoptosis: lack of a requirement for CD16-mediated events.
Ortaldo JR; Winkler-Pickett RT; Nagata S; Ware CF
J Leukoc Biol; 1997 Feb; 61(2):209-15. PubMed ID: 9021927
[TBL] [Abstract][Full Text] [Related]
9. Later development of Fas ligand-mediated cytotoxicity as compared with granule-mediated cytotoxicity during the maturation of natural killer cells.
Nakazawa T; Agematsu K; Yabuhara A
Immunology; 1997 Oct; 92(2):180-7. PubMed ID: 9415024
[TBL] [Abstract][Full Text] [Related]
10. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
[TBL] [Abstract][Full Text] [Related]
11. Fas-mediated cytotoxicity by freshly isolated natural killer cells.
Arase H; Arase N; Saito T
J Exp Med; 1995 Mar; 181(3):1235-8. PubMed ID: 7532682
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells.
Shiozawa M; Chang CH; Huang YC; Chen YC; Chi MS; Hao HC; Chang YC; Takeda S; Chi KH; Wang YS
BMC Immunol; 2018 Aug; 19(1):27. PubMed ID: 30075754
[TBL] [Abstract][Full Text] [Related]
13. Target-cell sensitivity to natural killer-cell lysis is determined by the expression of a novel antigen in conjunction with major histocompatibility complex class-I molecules.
Harris DT; Jaso-Friedmann L; Evans DL
Scand J Immunol; 1994 Jan; 39(1):73-8. PubMed ID: 8290895
[TBL] [Abstract][Full Text] [Related]
14. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.
Igarashi T; Wynberg J; Srinivasan R; Becknell B; McCoy JP; Takahashi Y; Suffredini DA; Linehan WM; Caligiuri MA; Childs RW
Blood; 2004 Jul; 104(1):170-7. PubMed ID: 15016654
[TBL] [Abstract][Full Text] [Related]
16. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
Komatsu F; Kajiwara M
Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
[TBL] [Abstract][Full Text] [Related]
17. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
[TBL] [Abstract][Full Text] [Related]
18. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46.
Spaggiari GM; Carosio R; Pende D; Marcenaro S; Rivera P; Zocchi MR; Moretta L; Poggi A
Eur J Immunol; 2001 Jun; 31(6):1656-65. PubMed ID: 11385609
[TBL] [Abstract][Full Text] [Related]
19. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
[TBL] [Abstract][Full Text] [Related]
20. Role for NK-cell-associated Fas ligand in cell-mediated cytotoxicity and apoptosis.
Eischen CM; Leibson PJ
Res Immunol; 1997; 148(3):164-9. PubMed ID: 9255868
[No Abstract] [Full Text] [Related]
[Next] [New Search]